Drug Type Recombinant polypeptide, Biosimilar |
Synonyms Teriparatide biosimilar (Gedeon Richter), rhPTH (1-34) (Gedeon Richter), テリパラチド + [3] |
Target |
Action agonists, stimulants |
Mechanism PTH1R agonists(Parathyroid hormone receptor agonists), Osteogenesis stimulants, Parathyroid hormone replacements |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date European Union (04 Jan 2017), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D06078 | Teriparatide(The Chemical Works of Gedeon Richter Plc) | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Primary osteoporosis | Australia | 01 Dec 2020 | |
Osteoporosis | Japan | 20 Sep 2019 | |
Glucocorticoid-induced osteoporosis | Iceland | 04 Jan 2017 | |
Glucocorticoid-induced osteoporosis | European Union | 04 Jan 2017 | |
Glucocorticoid-induced osteoporosis | Liechtenstein | 04 Jan 2017 | |
Glucocorticoid-induced osteoporosis | Norway | 04 Jan 2017 | |
Osteoporosis, Postmenopausal | Iceland | 04 Jan 2017 | |
Osteoporosis, Postmenopausal | European Union | 04 Jan 2017 | |
Osteoporosis, Postmenopausal | Norway | 04 Jan 2017 | |
Osteoporosis, Postmenopausal | Liechtenstein | 04 Jan 2017 | |
Osteoporotic Fractures | European Union | 04 Jan 2017 | |
Osteoporotic Fractures | Iceland | 04 Jan 2017 | |
Osteoporotic Fractures | Liechtenstein | 04 Jan 2017 | |
Osteoporotic Fractures | Norway | 04 Jan 2017 |